CME Group Inc. $CME Shares Bought by Naples Global Advisors LLC

Naples Global Advisors LLC increased its holdings in shares of CME Group Inc. (NASDAQ:CME) by 5.3% in the second quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 2,880 shares of the financial services provider’s stock after purchasing an additional 145 shares during the quarter. Naples Global Advisors LLC’s holdings in CME Group were worth $794,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also recently bought and sold shares of CME. Merit Financial Group LLC increased its position in CME Group by 105.8% during the 1st quarter. Merit Financial Group LLC now owns 11,929 shares of the financial services provider’s stock worth $3,165,000 after purchasing an additional 6,132 shares in the last quarter. Teamwork Financial Advisors LLC acquired a new stake in CME Group during the 1st quarter worth approximately $226,000. Nixon Peabody Trust Co. acquired a new stake in CME Group during the 1st quarter worth approximately $241,000. Portside Wealth Group LLC increased its position in CME Group by 2.1% during the 1st quarter. Portside Wealth Group LLC now owns 3,878 shares of the financial services provider’s stock worth $1,029,000 after purchasing an additional 78 shares in the last quarter. Finally, Beacon Financial Group increased its position in CME Group by 4.8% during the 1st quarter. Beacon Financial Group now owns 1,319 shares of the financial services provider’s stock worth $350,000 after purchasing an additional 61 shares in the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.

Insider Transactions at CME Group

In related news, insider Timothy Francis Mccourt sold 379 shares of the firm’s stock in a transaction on Tuesday, September 16th. The stock was sold at an average price of $259.83, for a total transaction of $98,475.57. Following the transaction, the insider directly owned 9,508 shares in the company, valued at $2,470,463.64. This trade represents a 3.83% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director William R. Shepard acquired 262 shares of CME Group stock in a transaction that occurred on Thursday, September 25th. The shares were purchased at an average price of $265.19 per share, for a total transaction of $69,479.78. Following the completion of the purchase, the director directly owned 258,459 shares of the company’s stock, valued at $68,540,742.21. The trade was a 0.10% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last ninety days, insiders have sold 13,043 shares of company stock valued at $3,527,956. Company insiders own 0.30% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms recently issued reports on CME. Barclays set a $298.00 target price on shares of CME Group and gave the stock an “equal weight” rating in a research report on Thursday, July 24th. Piper Sandler upped their price target on CME Group from $283.00 to $296.00 and gave the stock an “overweight” rating in a report on Tuesday, July 15th. Oppenheimer upped their price target on CME Group from $300.00 to $303.00 and gave the stock an “outperform” rating in a report on Thursday, July 24th. Citigroup upgraded CME Group from a “neutral” rating to a “buy” rating and upped their price target for the stock from $275.00 to $300.00 in a report on Thursday, September 25th. Finally, JPMorgan Chase & Co. upped their price target on CME Group from $246.00 to $252.00 and gave the stock an “underweight” rating in a report on Thursday, September 25th. Five analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $274.15.

CME Group Stock Performance

CME Group stock opened at $265.43 on Friday. The stock has a market cap of $95.66 billion, a P/E ratio of 25.70, a price-to-earnings-growth ratio of 4.83 and a beta of 0.41. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12. The stock has a 50 day moving average of $270.28 and a 200-day moving average of $271.11. CME Group Inc. has a 52 week low of $213.94 and a 52 week high of $290.79.

CME Group (NASDAQ:CME) last released its earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 EPS for the quarter, beating the consensus estimate of $2.91 by $0.05. The company had revenue of $1.69 billion during the quarter, compared to analysts’ expectations of $1.68 billion. CME Group had a return on equity of 14.60% and a net margin of 58.48%.The business’s revenue was up 10.4% on a year-over-year basis. During the same period in the prior year, the business posted $2.56 EPS. On average, analysts expect that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Thursday, September 25th. Stockholders of record on Tuesday, September 9th were paid a dividend of $1.25 per share. This represents a $5.00 annualized dividend and a dividend yield of 1.9%. The ex-dividend date was Tuesday, September 9th. CME Group’s dividend payout ratio is 48.40%.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.